Copyright
©The Author(s) 2022.
World J Clin Oncol. Nov 24, 2022; 13(11): 907-917
Published online Nov 24, 2022. doi: 10.5306/wjco.v13.i11.907
Published online Nov 24, 2022. doi: 10.5306/wjco.v13.i11.907
Classification | P value | |
Age | aOR 0.98 | < 0.01 |
Age 18-39 yr | Reference | |
Age 40-59 yr | aOR 2.60 | < 0.01 |
Age 60-79 yr | aOR 0.96 | 0.37 |
Age > 80 yr | aOR 0.46 | < 0.01 |
BMI: 18-24.9 | Reference | |
BMI: 25-29.9 | aOR 1.34 | < 0.01 |
BMI: 30-39.9 | aOR 0.62 | < 0.01 |
Women | aOR 0.65 | < 0.01 |
Whites | Reference | |
Blacks | 1.13 | < 0.01 |
Hispanics | 0.63 | < 0.01 |
Asians/Pacific Islanders | 0.50 | < 0.01 |
Native Americans | 1.05 | 0.31 |
Other | 0.67 | < 0.01 |
- Citation: Lew D, Kamal F, Phan K, Randhawa K, Cornwell S, Bangolo AI, Weissman S, Pandol SJ. Epidemiologic risk factors for patients admitted with chronic pancreatitis and pancreatic ductal adenocarcinoma in the United States. World J Clin Oncol 2022; 13(11): 907-917
- URL: https://www.wjgnet.com/2218-4333/full/v13/i11/907.htm
- DOI: https://dx.doi.org/10.5306/wjco.v13.i11.907